MISMATCH BINDING-PROTEINS AND TOLERANCE TO ALKYLATING-AGENTS IN HUMAN-CELLS

被引:27
|
作者
KARRAN, P
STEPHENSON, C
机构
[1] Imperial Cancer Research Fund, Laboratories, South Mimms,, Herts. Herts. EN6 3LD, Clare Hall
来源
MUTATION RESEARCH | 1990年 / 236卷 / 2-3期
关键词
Alkylating agents; DNA-repair enzyme; Mer phenotype; Mex phenotype; Mismatch binding proteins; N-Methyl-N′-nitro-N-nitrosoguanidine N-Methyl-N-nitrosourea;
D O I
10.1016/0921-8777(90)90010-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Mex- (Mer-) phenotype of human cells is characterised by a sensitivity to agents such as N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) and N-methyl-N-nitrosourea (MNU). The hypersensivity of Mex- cells is a consequence of their failure to express the DNA-repair enzyme m6-Gua-DNA methyltransferase. Resistance to MNNG and MNU may be acquired by Mex- cells either by reexpression of a methyltransferase function or by an ill-defined process of tolerance in which the cytotoxic potential of m6-Gua is circumvented without the altered base being removed from DNA. It has been suggested that tolerance might involve an altered mismatch correcting function. We have investigated proteins which recognise and bind specifically to DNA fragments containing single-base mismatches. Cell-free extracts of a Burkitt's lymphoma cell line (Raji) contain two such mismatch binding activities. Neither protein appears to have a high affinity for m6-Gua-containing base pairs. The data indicate that m6-Gua-containing base pairs might be poor substrates for mismatch repair processes in human cells. © 1990.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [1] INTERRELATIONSHIP OF THE 2 SPECIES OF FOLATE BINDING-PROTEINS IN HUMAN-CELLS
    KANE, MA
    ANTONY, AC
    KOLHOUSE, JF
    CLINICAL RESEARCH, 1984, 32 (02): : A310 - A310
  • [2] IMMUNOSUPPRESSION BY ALKYLATING-AGENTS - TOLERANCE INDUCTION
    AISENBERG, AC
    TRANSPLANTATION PROCEEDINGS, 1973, 5 (03) : 1221 - 1226
  • [3] ACQUISITION OF RESISTANCE TO ALKYLATING-AGENTS BY EXPRESSION OF METHYLTRANSFERASE GENE IN REPAIR-DEFICIENT HUMAN-CELLS
    SEKIGUCHI, M
    HAYAKAWA, H
    KODAMA, K
    ISHIZAKI, K
    IKENAGA, M
    DNA REPAIR MECHANISMS AND THEIR BIOLOGICAL IMPLICATIONS IN MAMMALIAN CELLS, 1989, 182 : 73 - 81
  • [4] ALKYLATING-AGENTS AND MYELOMA CELLS
    PILERI, A
    CONTE, PF
    HULIN, N
    BLOOD, 1976, 47 (06) : 1056 - 1056
  • [5] INTERACTION BETWEEN PROTEINS AND ANTINEOPLASTIC ALKYLATING-AGENTS
    ALLEN, LM
    CREAVEN, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1972, 164 (AUG-S): : 145 - &
  • [6] ALKYLATING-AGENTS AS PROBES FOR THE BINDING OF MICROTUBULE-ASSOCIATED PROTEINS (MAPS) TO TUBULIN
    ROACH, MC
    BINKLEY, P
    JORDAN, MA
    JOURNAL OF CELL BIOLOGY, 1982, 95 (02): : A347 - A347
  • [7] SENSITIVITY OF SUPPRESSOR CELLS TO ALKYLATING-AGENTS
    GHAFFAR, A
    PAUL, R
    SIGEL, MM
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1978, 23 (06): : I5 - I5
  • [8] EFFECT OF PREDNISOLONE ON CHROMATIN BINDING OF ALKYLATING-AGENTS
    THRAVES, PJ
    SHEPHERD, R
    JENEY, A
    HARRAP, KR
    BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 171 - 172
  • [9] AGE SENSITIVITY OF HUMAN CHROMOSOMES TO ALKYLATING-AGENTS
    BOCHKOV, NP
    KULESHOV, NP
    MUTATION RESEARCH, 1972, 14 (03): : 345 - &
  • [10] DNA-DAMAGE IN HUMAN-CELLS TREATED WITH THE CLOSELY RELATED ALKYLATING-AGENTS PEPTICHEMIO, M-L-SARCOLYSIN AND MELPHALAN
    RINGBORG, U
    LAMBERT, B
    LEWENSOHN, R
    TURESSON, I
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (09): : 991 - 996